Our 36,000 ft² research facility houses our corporate headquarters, our inpatient clinical research facility and our outpatient clinic. The Outpatient and Assessment Unit functions as a screening and assessment area for our Phase I trials.

First in Human and Proof of Concept Studies

Based on our expertise in early-phase research, DecisionLine can help demonstrate your compound's safety and clinical efficacy by:

• Demonstrating the safety and dose tolerability of the compound
• Identifying potential side-effect manifestations
• Validating the relevance of novel therapeutic targets and in vivo preclinical models to man
• Defining potential biological markets for clinical efficacy or toxicity
• Providing earlier evidence of the potential to show clinical efficacy
• Rapidly eliminating potential failures